Just as the climate is not static, nor should we be.

Our Tempest Rising review breaks down what makes this sci-fi real-time strategy game interesting, in spite of its overly familiar structure. New to Shacknews? Signup for a Free Account.

Note: This review specifically covers the multiplayer mode of Tempest Rising. For thoughts on the story mode, check out the Tempest Rising single-player campaign review. The problem with Tempest ...

As for the Tempest Rising recommended specs, these take a hearty jump up, asking for an Nvidia GeForce RTX 3060 Ti or AMD Radeon RX 7600 XT paired with an Intel Core i5 11600K or AMD Ryzen 5 5600X ...

Tempest plans to complete the significant reduction in its head count by April 30. The biotech expects the action to cost it about $1.5 million, mainly in the form of severance payments.

Base-building RTS Tempest Rising released on Steam yesterday, a full week before it was supposed to, and the publisher doesn't see a good way out of it, so the game just has a new release date now ...

Tempest Rising is at its best when battles are smaller scale and lower stakes. It works when you're controlling a limited number of soldiers and vehicles, and when your objectives are specific.

Tempest Rising's first major update targets the Command and Conquer successor's multiplayer, adding 6 maps, a 2v2 ranked mode, and an extensive balance overhaul; The best strategy games on PC; ...

Tempest Rising is a polished, performant and brilliant real-time strategy (RTS) game powered by Unreal Engine 5. That's a sentence I never really expected to say just a few years ago, ...

Tempest Therapeutics hires MTS Health to explore M&A and partnerships after Roche shows limited interest in its liver cancer program.

Unable to secure additional financing amid a stormy market, Tempest Therapeutics has put a call out for partners as it seeks to take its liver cancer drug into phase 3.. The Brisbane, California ...

Tempest ended 2024 with just over $30 million in cash and equivalents, which it cautioned was not enough to fully fund a Phase 3 trial. Brady said “the capital markets have been unavailable ...